Literature DB >> 26363795

The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy.

Cheng-Cheng Zhang1, Ang Xing2, Meng-Shan Tan3, Lan Tan4,5, Jin-Tai Yu6,7.   

Abstract

Microtubule-associated protein tau (MAPT) is a gene responsible for encoding tau protein, which is tightly implicated in keeping the function of microtubules and axonal transport. Hyperphosphorylated tau protein participates in the formation of neurofibrillary tangles (NFTs), which characterize many neurodegenerative disorders termed tauopathies. Genome-wide association studies (GWAS) have demonstrated numerous single nucleotide polymorphisms (SNPs) located in MAPT associated with various neurodegenerative diseases. Thus, it has been presumed that MAPT plays a crucial role in pathogenesis of neurodegeneration via affecting the structure and function of tau. Here, we review the advanced studies to summarize the biochemical properties of MAPT and its encoded protein, as well as the genetics and epigenetics of MAPT in neurodegeneration. Finally, given the potential mechanisms of MAPT to neurodegeneration pathogenesis, targeting MAPT and tau might present significant treatments of MAPT mutation-related neurodegeneration. Affirmatively, the identification of MAPT is extremely beneficial for improving our understanding of the pathogenesis of various neurodegenerative diseases and developing the mechanism-based therapies.

Entities:  

Keywords:  Genetics; MAPT; Neurodegeneration; Pathogenesis; Therapy

Mesh:

Substances:

Year:  2015        PMID: 26363795     DOI: 10.1007/s12035-015-9415-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  127 in total

1.  Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish.

Authors:  Frauke van Bebber; Dominik Paquet; Alexander Hruscha; Bettina Schmid; Christian Haass
Journal:  Neurobiol Dis       Date:  2010-04-08       Impact factor: 5.996

2.  Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome.

Authors:  Jonathan D Rohrer; Dominic Paviour; Jana Vandrovcova; John Hodges; Rohan de Silva; Martin N Rossor
Journal:  Neurodegener Dis       Date:  2010-09-14       Impact factor: 2.977

3.  Nuclear tau, a key player in neuronal DNA protection.

Authors:  Audrey Sultan; Fabrice Nesslany; Marie Violet; Séverine Bégard; Anne Loyens; Smail Talahari; Zeyni Mansuroglu; Daniel Marzin; Nicolas Sergeant; Sandrine Humez; Morvane Colin; Eliette Bonnefoy; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

4.  Abeta(1-42) induces abnormal alternative splicing of tau exons 2/3 in NGF-induced PC12 cells.

Authors:  Teresa Lagunes; Marisol Herrera-Rivero; María Elena Hernández-Aguilar; Gonzalo E Aranda-Abreu
Journal:  An Acad Bras Cienc       Date:  2014-11-28       Impact factor: 1.753

5.  Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.

Authors:  Tara L Spires-Jones; Taylor Friedman; Rose Pitstick; Manuela Polydoro; Allyson Roe; George A Carlson; Bradley T Hyman
Journal:  Neurosci Lett       Date:  2014-01-21       Impact factor: 3.046

Review 6.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

7.  Interaction of tau protein with the dynactin complex.

Authors:  Enrico Magnani; Juan Fan; Laura Gasparini; Matthew Golding; Meredith Williams; Giampietro Schiavo; Michel Goedert; Linda A Amos; Maria Grazia Spillantini
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

8.  Cornel Iridoid Glycoside Attenuates Tau Hyperphosphorylation by Inhibition of PP2A Demethylation.

Authors:  Cui-Cui Yang; Xue-Xian Kuai; Ya-Li Li; Li Zhang; Jian-Chun Yu; Lin Li; Lan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-19       Impact factor: 2.629

9.  Mutations in MAPT give rise to aneuploidy in animal models of tauopathy.

Authors:  Giacomina Rossi; Donatella Conconi; Elena Panzeri; Laura Paoletta; Elena Piccoli; Maria Giulia Ferretti; Michela Mangieri; Margherita Ruggerone; Leda Dalprà; Fabrizio Tagliavini
Journal:  Neurogenetics       Date:  2013-11-12       Impact factor: 2.660

Review 10.  Microglia in Alzheimer's disease.

Authors:  Ying Li; Meng-Shan Tan; Teng Jiang; Lan Tan
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

View more
  12 in total

Review 1.  The role of UNC5C in Alzheimer's disease.

Authors:  Quan Li; Bai-Ling Wang; Fu-Rong Sun; Jie-Qiong Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

2.  Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology.

Authors:  Sarah E Monsell; Charles Mock; David W Fardo; Sarah Bertelsen; Nigel J Cairns; Catherine M Roe; Sally R Ellingson; John C Morris; Alison M Goate; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jul-Sep       Impact factor: 2.703

3.  Widespread Tau-Specific CD4 T Cell Reactivity in the General Population.

Authors:  Cecilia S Lindestam Arlehamn; John Pham; Roy N Alcalay; April Frazier; Evan Shorr; Chelsea Carpenter; John Sidney; Rekha Dhanwani; Julian Agin-Liebes; Francesca Garretti; Amy W Amara; David G Standaert; Elizabeth J Phillips; Simon A Mallal; Bjoern Peters; David Sulzer; Alessandro Sette
Journal:  J Immunol       Date:  2019-05-13       Impact factor: 5.422

4.  Neuroprotective Functions for the Histone Deacetylase SIRT6.

Authors:  Shai Kaluski; Miguel Portillo; Antoine Besnard; Daniel Stein; Monica Einav; Lei Zhong; Uwe Ueberham; Thomas Arendt; Raul Mostoslavsky; Amar Sahay; Debra Toiber
Journal:  Cell Rep       Date:  2017-03-28       Impact factor: 9.423

5.  Astrocytes modulate neurodegenerative phenotypes associated with glaucoma in OPTN(E50K) human stem cell-derived retinal ganglion cells.

Authors:  Cátia Gomes; Kirstin B VanderWall; Yanling Pan; Xiaoyu Lu; Sailee S Lavekar; Kang-Chieh Huang; Clarisse M Fligor; Jade Harkin; Chi Zhang; Theodore R Cummins; Jason S Meyer
Journal:  Stem Cell Reports       Date:  2022-06-16       Impact factor: 7.294

Review 6.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

7.  Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis.

Authors:  Shelby Meier; Michelle Bell; Danielle N Lyons; Jennifer Rodriguez-Rivera; Alexandria Ingram; Sarah N Fontaine; Elizabeth Mechas; Jing Chen; Benjamin Wolozin; Harry LeVine; Haining Zhu; Jose F Abisambra
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

Review 8.  Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Authors:  Cheng-Cheng Zhang; Jun-Xia Zhu; Yu Wan; Lin Tan; Hui-Fu Wang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2017-07-04

9.  Proteomic Investigations of Autism Brain Identify Known and Novel Pathogenetic Processes.

Authors:  Joseph R Abraham; Nicholas Szoko; John Barnard; Robert A Rubin; Daniela Schlatzer; Kathleen Lundberg; Xiaolin Li; Marvin R Natowicz
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

10.  Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes.

Authors:  Anna Vasilevskaya; Foad Taghdiri; Charles Burke; Apameh Tarazi; Seyed Ali Naeimi; Mozghan Khodadadi; Ruma Goswami; Christine Sato; Mark Grinberg; Danielle Moreno; Richard Wennberg; David Mikulis; Robin Green; Brenda Colella; Karen D Davis; Pablo Rusjan; Sylvain Houle; Charles Tator; Ekaterina Rogaeva; Maria C Tartaglia
Journal:  Neuroimage Clin       Date:  2020-02-13       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.